Dosimetric feasibility analysis and presentation of an isotoxic dose-escalated radiation therapy concept for glioblastoma used in the PRIDE trial (NOA-28; ARO-2022-12)

DSpace Repository

Dosimetric feasibility analysis and presentation of an isotoxic dose-escalated radiation therapy concept for glioblastoma used in the PRIDE trial (NOA-28; ARO-2022-12)

Author: Bodensohn, Raphael; Fleischmann, Daniel F.; Maier, Sebastian H.; Anagnostatou, Vasiliki; Garny, Sylvia; Nitschmann, Alexander; Buettner, Marcel; Muecke, Johannes; Schoenecker, Stephan; Unger, Kristian; Hoffmann, Elgin; Paulsen, Frank; Thorwarth, Daniela; Holzgreve, Adrien; Albert, Nathalie L.; Corradini, Stefanie; Tabatabai, Ghazaleh; Belka, Claus; Niyazi, Maximilian
Tübinger Autor(en):
Bodensohn, Raphael
Fleischmann, Daniel F.
Büttner, Marcel
Hoffmann, Elgin
Paulsen, Frank
Thorwarth, Daniela
Tabatabai, Ghazaleh
Niyazi, Maximilian
Published in: Clinical and Translational Radiation Oncology (2024), Bd. 45, Article 100706
Verlagsangabe: Clare : Elsevier Ireland Ltd
Language: English
Full text: http://dx.doi.org/10.1016/j.ctro.2023.100706
ISSN: 2405-6308
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)